Late Breaking Abstract - Enhanced expression of IL-1ß in later stage of influenza A virus infection is independent of NLRP3 in vitro

Y. Shi (GuangZhou, China), X. Shi (GuangZhou, China), J. Liang (GuangZhou, China), J. Luo (GuangZhou, China), J. Ba (GuangZhou, China), B. Wu (GuangZhou, China)

Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Session: Experimental and laboratory studies in intensive care unit medicine
Session type: E-poster session
Number: 2741
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Shi (GuangZhou, China), X. Shi (GuangZhou, China), J. Liang (GuangZhou, China), J. Luo (GuangZhou, China), J. Ba (GuangZhou, China), B. Wu (GuangZhou, China). Late Breaking Abstract - Enhanced expression of IL-1ß in later stage of influenza A virus infection is independent of NLRP3 in vitro. 2741

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - The pro-inflammatory activity and role of NLRP3 inflammasome in severe influenza A virus pneumonia.
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021


Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020


Late Breaking Abstract - Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021



Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018


Impact of IL-13 on RSV infection in vitro and in vivo
Source: Annual Congress 2013 –Viral infections
Year: 2013

Late Breaking Abstract: Suppressed rhinovirus (RV) induced type III interferon production in alternatively activated macrophages
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010

LSC 2014 abstract - Influenza infection of human lung macrophages increases PDL1 expression via autologous IFNbeta
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014

Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Human respiratory syncytial virus infection in vivo and in vitro induces expression of the B cell differentiation factor BAFF
Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences
Year: 2011


Late Breaking Abstract - Efficient replication of respiratory syncytial virus induces a decrease of mucociliary clearance in human small airway 3D culture
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018


Abortive replication and reactivation in vitro respiratory syncytial virus (RSV) infection in palivizumab-treated HeLa cells
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Influenza infection of human lung macrophages increases PDL1 expression
Source: Annual Congress 2013 –Viral infections
Year: 2013

Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016

Impaired viral clearance after influenza infection in IDO transgenic mice
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005


Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019



Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017



Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


Long-term derangement of antigen presenting cells in the respiratory tract of mice following influenza virus infection
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013

Late Breaking Abstract - Transcriptional response to RSV in asthma primary bronchial epithelial cells: are the basal cells responsible for the reduced NF-kB response?
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021